Literature DB >> 9115038

Multicentric and multifocal primary cerebral tumours. Methods of diagnosis and treatment.

M Salvati1, L Cervoni, P Celli, R Caruso, F M Gagliardi.   

Abstract

Forty patients with multifocal and multicentric cerebral tumours were retrospectively studied. The patients were divided into two groups: ten patients with multicentric tumours (group A), and 30 patients with multifocal tumours. As far as their preoperative clinical history and the incidence of the various symptoms and signs are concerned, there were no significant differences between the two groups. CT permitted a correct diagnosis in 90% of the cases. All of the patients underwent the removal of the tumour(s) and received radiotherapy; 30 patients also received chemotherapy. In group A, nine patients died and one was lost to follow-up one year after treatment; the average survival was ten months from the appearance of the multicentric tumour. In group B, 29 patients died and one is still alive two years after treatment; the average survival was six months. We consider the problems of diagnosis and the long-term follow-up of patients.

Entities:  

Mesh:

Year:  1997        PMID: 9115038     DOI: 10.1007/bf02106225

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN: 0392-0461


  3 in total

1.  The incidence and significance of multicentric noncontrast-enhancing lesions distant from a histologically-proven glioblastoma.

Authors:  Arian Lasocki; Frank Gaillard; Mark A Tacey; Katharine J Drummond; Stephen L Stuckey
Journal:  J Neurooncol       Date:  2016-07-13       Impact factor: 4.130

2.  Multifocal and multicentric glioblastoma with leptomeningeal gliomatosis: a case report and review of the literature.

Authors:  Sophia F Shakur; Esther Bit-Ivan; William G Watkin; Ryan T Merrell; Hamad I Farhat
Journal:  Case Rep Med       Date:  2013-12-05

Review 3.  Multiple cerebral gliomas mimicking central nervous system inflammatory demyelinating diseases: A rare case with review of literature.

Authors:  Yong-Jie Xiong; Xin-Ling Zhao; Xiao-Yan Wang; Deng-Ji Pan; Dai-Shi Tian
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.